On March 4, 2024, the management of the company held a remote video conference call with the chief representative of the Indonesian branch and related agencies. We communicated with each other about the development of the company's medical sector in the Indonesian market, learned about the sales policies of medical drugs in the Indonesian market and other related issues, and made plans for the next step.